ZNF350 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.715000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.825830E-01
Normal-vs-Stage2
5.657600E-03
Normal-vs-Stage3
4.828100E-02
Normal-vs-Stage4
2.634600E-01
Stage1-vs-Stage2
4.048000E-01
Stage1-vs-Stage3
3.143200E-01
Stage1-vs-Stage4
7.024600E-01
Stage2-vs-Stage3
4.620000E-01
Stage2-vs-Stage4
2.185200E-01
Stage3-vs-Stage4
1.185020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.084500E-03
Normal-vs-AfricanAmerican
2.399500E-02
Normal-vs-Asian
8.052100E-02
Caucasian-vs-AfricanAmerican
6.517800E-01
Caucasian-vs-Asian
9.508000E-01
AfricanAmerican-vs-Asian
7.194600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.759300E-03
Normal-vs-Female
5.897300E-03
Male-vs-Female
2.912600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.224800E-01
Normal-vs-Age(41-60Yrs)
1.642130E-02
Normal-vs-Age(61-80Yrs)
5.018000E-03
Normal-vs-Age(81-100Yrs)
7.180300E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.167800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.532800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.018400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.199500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.340400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.587200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.559000E-03
Normal-vs-Daily Drinker
1.104450E-02
Normal-vs-Weekly Drinker
6.480400E-03
Normal-vs-Occasional Drinker
2.804000E-02
Normal-vs-Social Drinker
1.079800E-02
Non Drinker-vs-Daily Drinker
4.638400E-01
Non Drinker-vs-Weekly Drinker
7.553800E-01
Non Drinker-vs-Occasional Drinker
1.557790E-02
Non Drinker-vs-Social Drinker
4.893200E-01
Daily Drinker-vs-Weekly Drinker
7.373200E-01
Daily Drinker-vs-Occasional Drinker
1.118040E-01
Daily Drinker-vs-Social Drinker
9.903000E-01
Weekly Drinker-vs-Occasional Drinker
5.484100E-02
Weekly Drinker-vs-Social Drinker
7.297000E-01
Occasional Drinker-vs-Social Drinker
1.208410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.091600E-01
Normal-vs-Grade 2
4.980000E-02
Normal-vs-Grade 3
8.868000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.457600E-01
Grade 1-vs-Grade 3
9.483200E-01
Grade 1-vs-Grade 4
2.091600E-01
Grade 2-vs-Grade 3
9.970200E-01
Grade 2-vs-Grade 4
4.980000E-02
Grade 3-vs-Grade 4
8.868000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.556490E-03
Normal-vs-NonDiabetic
6.697900E-03
Diabetic-vs-NonDiabetic
1.897150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.097000E-03
Normal-vs-NoPancreatitis
4.757400E-03
Pancreatitis-vs-NoPancreatitis
2.464400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.322800E-03
Normal-vs-N1
6.563600E-03
N0-vs-N1
9.003800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.532100E-02
Normal-vs-TP53-NonMutant
2.339900E-02
TP53-Mutant-vs-TP53-NonMutant
4.161800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
